To examine the relation of cigarette smoking and alcohol consumption to serum fatty acid levels, the authors conducted a cross-sectional study of 190 men who were enrolled in the Murtiple Risk Factor Intervention Trial between 1973 and 1976. After controlling for dietary fat, cholesterol, energy intake, and other potential confounders, the authors found that smoking and alcohol intake were associated with the serum cholesterol ester and phospholipid levels of several fatty acids. As the number of cigarettes smoked per day increased, the levels of cholesterol ester and phospholipid palmitoleic acid (16:1) and oleic acid (18:1) and the levels of phospholipid dihomogammalinolenic acid (20:3) and omega-9 eicosatrienoic acid (20:3) increased (all p's < 0.01). Serum levels of phospholipid omega-3 docosahexaenoic acid (22:6) and cholesterol ester and phospholipid arachidonic acid (20:4) were inversely associated with smoking (all p's £ 0.01). As the number of alcoholic drinks per week increased, levels of cholesterol ester and phospholipid palmitic acid (16:0) and oleic acid (18:1), cholesterol ester myristic acid (14:0), and phospholipid palmitoleic acid (16:1), adrenic acid (22:4), and omega-9 eicosatrienoic acid (20:3) increased (all p's < 0.05), whereas levels of cholesterol ester and phospholipid linoleic acid (18:2) and phospholipid stearic acid (18:0) and the serum polyunsaturated fat: saturated fat ratio decreased (all p's £ 0.01). These results suggest that smoking and alcohol consumption may influence the absorption, synthesis, or metabolism of serum fatty acids. Studies that use serum fatty acid levels as indicators of dietary fat intake should control for the effects of cigarette smoking and alcohol consumption. Am J Epidemiol 1996;144:325-34. alcohol drinking; alcohol, ethyl; coronary disease; diet; fatty acids; smoking; tobacco Part of the increased coronary heart disease risk associated with cigarette smoking and the decreased risk associated with moderate alcohol consumption may result from changes in lipid and lipoprotein levels and platelet reactivity (1-3). We hypothesized that
smoking and alcohol consumption may affect coronary heart disease risk partly through their effects on the fatty acid composition of serum cholesterol esters and phospholipids. Such changes in fatty acid composition could influence blood clotting (4) and, in turn, the risk of coronary heart disease. We have shown in previous work that the serum level of cholesterol ester palmitic acid (16:0) is directly associated with coronary heart disease risk, whereas serum levels of phospholipid docosapentaenoic acid (22:5) and docosahexaenoic acid (22:6) , omega-3 fatty acids, are inversely associated with coronary heart disease risk (5) . We also found that the level of cholesterol ester alpha-linolenic acid (18:3) , the parent compound of the omega-3 class of fatty acids, is inversely associated with the risk of stroke (6) . These associations were independent of other cardiovascular disease risk factors.
Biochemical fatty acid profiles of serum lipids generally reflect established patterns of fatty acid intake (7) . Correlations between dietary intake, as estimated by food frequency questionnaires, and the plasma fatty acid composition of cholesterol esters and phospholipids have been reported to range from approximately 0.2 to 0.3 for diet-derived essential polyunsaturated fatty acids, such as linoleic acid (18:2) and alphalinolenic acid (18:3) , and from 0.2 to 0.4 for eicosapentaenoic acid (20:5) and docosahexaenoic acid (22:6) (8) . Nonessential saturated and monounsaturated fatty acids are less reliable indicators of dietary fatty acid intake, because these levels also reflect fatty acid synthesis and metabolism.
In order to examine the relation of smoking and alcohol consumption to serum fatty acid composition, we conducted a cross-sectional analysis of data collected from a subset of 190 men in the Multiple Risk Factor Intervention Trial (MRFIT), using stored frozen serum samples that had been collected at the outset of the study.
MATERIALS AND METHODS

Subjects
MRFIT was a primary coronary heart disease prevention trial that studied the effects of cholesterol and blood pressure lowering and smoking cessation among men at high risk for coronary disease. Between December 1973 and February 1976, 12 ,866 US men aged 35-57 years were enrolled and randomly assigned to either a Special Intervention group or a Usual Care group after screening was completed (9) . Men in the Usual Care group (n = 6,438) continued their usual medical care and were evaluated yearly by MRFIT staff (10) .
We analyzed data from 190 men in the Special Intervention and Usual Care groups who served as control subjects in two nested case-control studies that examined the relation of serum fatty acid levels to incident coronary heart disease and incident stroke (5, 6) . Because of missing data on plasma lipid and glucose levels, 186 of these men were included in the analysis.
Measurements
At baseline, subjects were weighed after removing their shoes and outdoor clothing. Seated blood pressure was measured in mmHg using a random-zero manometer and a cuff size appropriate for arm circumference. Three blood pressure readings were obtained, and the average of the second and third readings was recorded. Tobacco use (cigarettes per day) and alcohol intake (drinks per week) were determined by selfreport, and nutrient intake at baseline was estimated using a 24-hour diet recall. These methods have been described in detail elsewhere (10, 11) .
Fasting plasma total cholesterol, low density lipoprotein cholesterol, high density lipoprotein cholesterol, triglyceride, and glucose levels were determined at baseline. At the Centers for Disease Control and Prevention, we measured lipoprotein fatty acid levels from serum specimens obtained at baseline and frozen at -55°C for the entire interim period. We extracted serum aliquots by the procedure of Folch et al. (12) , isolated the cholesterol esters and phospholipids by thin-layer chromatography, and transesterified them to the methyl esters (13) . We purified the fatty acid methyl esters on a small silicic acid column and analyzed them by capillary gas-liquid chromatography on a 0.2-mm X 50-m FFAP column mounted in a Hewlett-Packard 5880 gas chromatograph (HewlettPackard Company, Palo Alto, California) (14) . The instrument was calibrated before each series of analyses using a quantitative standards mixture (GLC-68A) from Nu Chek Prep (Elysian, Minnesota). Specific fatty acid levels were expressed as the percentage of total fatty acids in the cholesterol ester and phospholipid fractions. Only identified fatty acid peaks were used to estimate the fatty acid composition of the cholesterol esters and phospholipids. We chose to measure and examine the fatty acid composition of serum cholesterol esters and phospholipids rather than that of serum triglycerides, because of their longer half-life. The fatty acid composition of serum cholesterol esters and phospholipids may better reflect usual dietary fatty acid intake patterns (13) .
We evaluated the stability of the frozen serum specimens prior to this analysis. We analyzed 12 randomly selected samples for their malondialdehyde (15) and conjugated diene (16) content. We also assayed Folch extracts of the samples for fluorescent degradation products, their vitamin A and E content (17) , and fatty acid profiles. Comparison of the results with reference pools and fresh serum indicated that very little oxidative damage had occurred. There were minor but statistically significant increases in malondialdehyde and conjugated diene content in comparison with fresh serum (p < 0.02). sition) using general linear models. We verified that a linear model was appropriate by examining the association between smoking and serum fatty acid levels across all four categories of smoking, checking for evidence of nonlinear relations. We performed univariate regression, examining the relation of smoking and alcohol consumption to each fatty acid, and then performed multivariate regression, adjusting for age, body mass index, plasma glucose, total energy intake, cholesterol intake, polyunsaturated fatty acid intake, monounsaturated fatty acid intake, saturated fatty acid intake, and the MRFTT selection criteria (plasma cholesterol level and diastolic blood pressure). Smoking and alcohol consumption were included in all multivariate models. Because the quadratic terms for alcohol intake were statistically significant for two fatty acids, cholesterol ester stearic acid (18:0) and palmitoleic acid (16:1), multivariate models that examined the relation between smoking and alcohol consumption and the cholesterol ester fatty acids stearic acid and palmitoleic acid included alcohol intake as both a linear and a quadratic term.
We determined the correlations between the dietary intake variables to evaluate the possibility of collinearity. The strongest correlation was between monounsaturated fat intake and polyunsaturated fat intake (r = 0.6). Because multivariate models that included and excluded monounsaturated fat intake produced virtually identical results, we chose to present the findings from models that included monounsaturated fat intake.
We calculated univariate and multivariate regression coefficients and their 95 percent confidence intervals. With the exception of phospholipid eicosapentaenoic acid (20:5) values, which required logarithmic transformation, data on the fatty acid variables generally had approximately normal distributions. Using the slopes and 95 percent confidence intervals derived from the multivariate models, we estimated the relative percentage differences in serum fatty acid levels accounted for by smoking and alcohol consumption (i.e., the predicted difference divided by the absolute percentage of each fatty acid in the cholesterol ester and phospholipid fractions). We considered two-tailed p values less than 0.05 to be statistically significant, unadjusted for multiple comparisons (18) . SAS software was used in all statistical analyses (19) .
RESULTS
Although the men recruited for MRFIT were at increased risk for coronary heart disease because they smoked, had high diastolic blood pressures, or had high plasma cholesterol levels, over 50 percent of the MRFIT subjects analyzed in this study were nonsmokers (table 1) . Six percent of our study subjects were nondrinkers, and 4 percent were heavy drinkers (^5 alcoholic drinks per day). On average, however, most of the men consumed one or two drinks per day.
Consistent with previous observations (20) , the principal fatty acids in the serum cholesterol ester fraction were oleic acid (18:1) and the omega-6 fatty acid linoleic acid (18:2) (table 2) . There was a wider distribution of fatty acids in the phospholipid fraction, including the omega-3 fatty acids eicosapentaenoic acid (20:5), docosapentaenoic acid (22:5), and docosahexaenoic acid (22:6).
Cigarette smoking
In univariate analyses, smoking was associated with higher serum levels of myristic acid (14:0), palmitoleic acid (16:1), oleic acid (18:1), alpha-linolenic acid (18:3), dihomogammalinolenic acid (20:3), and omega-9 eicosatrienoic acid (20:3) (all p's < 0.05). Smoking was associated with lower serum levels of docosahexaenoic acid (22:6), linoleic acid (18:2), and arachidonic acid (20:4) (ally's ^ 0.01). Smoking was also associated with a lower serum polyunsaturated: saturated fatty acid ratio (all p's < 0.05). For serum fatty acids that were significant in univariate analyses, we compared the mean serum fatty acid level in each of the four smoking categories (0, 1-20, 21-40, and >40 cigarettes per day). With the exception of arachidonic acid, there were monotonic increases or decreases in the mean serum fatty acid level as smoking increased. Mean arachidonic acid levels remained unchanged at 20 cigarettes or less per day, but they decreased consistently among subjects who smoked more than 20 cigarettes per day.
In multivariate analyses, we found that smoking was independently associated with higher levels of palmitoleic acid (16:1), oleic acid (18:1), phospholipid dihomogammalinolenic acid (20:3), and omega-9 eicosatrienoic acid (20:3) and with lower levels of docosahexaenoic acid (22:6) and arachidonic acid (20:4) (all p's < 0.01) (table 3). The serum polyunsaturated : saturated fatty acid ratio was not associated with smoking after multivariate adjustment.
Alcohol consumption
In univariate analyses, alcohol consumption was associated with higher serum levels of myristic acid (14:0), palmitic acid (16:0), palmitoleic acid (16:1), oleic acid (18:1), alpha-linolenic acid (18:3), adrenic acid (22:4), log eicosapentaenoic acid (20:5) , and omega-9 eicosatrienoic acid (20:3) (all p's < 0.05). Alcohol consumption was associated with lower serum levels of stearic acid (18:0) and linoleic acid (18:2) and a lower serum polyunsaturated fatty acid: saturated fatty acid ratio (all p's ^ 0.01). In multivariate analyses, we found that alcohol consumption was independently associated with higher levels of cholesterol ester myristic acid (14:0), palmitic acid (16:0), and oleic acid (18:1) and phospholipid palmitic acid, palmitoleic acid (16:1), oleic acid, adrenic acid (22:4), and omega-9 eicosatrienoic acid (20:3). Alcohol consumption was independently associated with lower levels of phospholipid stearic acid (18:0) and cholesterol ester and phospholipid linoleic acid (18:2) (all p's < 0.05) (table 4). The serum polyunsaturated fatty acid: saturated fatty acid ratio remained inversely associated with alcohol intake after multivariate adjustment (p < 0.01).
The relations between alcohol consumption and levels of cholesterol ester stearic acid (18:0) and palmitoleic acid (16:1) were nonlinear. As alcohol consumption increased from 0 to 30 drinks per week, the level of cholesterol ester stearic acid decreased. At higher levels of alcohol consumption, however, the level of cholesterol ester stearic acid increased. As the level of alcohol consumption increased, the level of cholesterol ester palmitoleic acid generally increased, although not monotonically, as reflected in a statistically significant alcohol 2 term (p = 0.01).
Predicted effects on serum fatty acid levels
Smoking and alcohol consumption had substantial predicted effects on several cholesterol ester and phospholipid fatty acids (table 5) . For example, heavy smokers (>40 cigarettes per day) had 54 percent higher levels of phospholipid palmitoleic acid (16:1) and 30 percent lower levels of phospholipid docosahexaenoic acid (22:6) than nonsmokers. The predicted effects of alcohol consumption were most notable for palmitoleic acid (16:1), where every 10 drinks consumed per week were associated with a 21 percent increase in phospholipid palmitoleic acid levels. t Slope denotes absolute percentage difference in fatty acid level (e.g., 0.03 denotes 0.03%) for every 10 drinks per week, adjusted for age, body mas3 index, smoking, plasma glucose level, total calories, cholesterol intake, intake of polyunsaturated, monounsaturated, and saturated fatty acids, diastolic blood pressure, and plasma cholesterol level. Multivariate models for cholesterol ester stearic acid (18:0) and palmitoleic acid (16:1) also included alcohol 2 . £ Cl, confidence interval. § Slope for alcohol 2 . II Slope for log eicosapentaenoic acid.
DISCUSSION
Cigarette smoking and alcohol consumption were independently associated with the serum lipoprotein levels of several cholesterol ester and phospholipid fatty acids. These associations were present after adjustment for dietary fat, energy, cholesterol, and body mass index.
Saturated fatty acids
Although higher blood levels of saturated fatty acids are associated with an increased risk of coronary heart disease (5, 21-23), we did not find any association between smoking and saturated fatty acid levels. However, alcohol consumption was associated with higher levels of palmitic acid (16:0) and myristic acid (14:0) and lower levels of phospholipid stearic acid (18:0). In agreement with our findings, some previous reports found that alcohol consumption was independently associated with higher levels of palmitic acid (24) and lower levels of stearic acid (25) . In contrast, Cambien et al. (25) reported lower levels of myristic acid as alcohol consumption increased. Because higher serum levels of palmitic acid have been associated with increased risk of coronary heart disease (5, 22, 23, 26) and because moderate alcohol consumption is associated with a lower risk of coronary heart disease (7), these findings suggest that other effects of alcohol, such as an increase in high density lipoprotein cholesterol levels, outweigh any potentially adverse effects of alcohol on palmitic acid or myristic acid.
Monounsaturated fatty acids
Several studies have reported that higher serum and adipose tissue levels of palmitoleic acid (16:1) are 12 to 29 * The predicted effect is the percentage difference in serum fatty acid levels that is accounted for by smoking and alcohol consumption, divided by the absolute percentage of each fatty acid in the cholesterol ester and phospholipid fractions. Results were adjusted br age, body mass index, smoking, alcohol intake, plasma glucose level, total calories, cholesterol intake, intake of polyunsaturated, monounsaturated, and saturated fatty acids, diastolic blood pressure, and plasma cholesterol level. Multtvanate models for cholesterol ester paJmitoleic acid (16:1) also included alcohol'.
t Cl, confidence interval. i Compares the nonsmoking category with the heaviest smoking category (>40 cigarettes/day).
§ Per 10 drinks per week.
associated with coronary heart disease (26-29) and stroke (30) . Other studies have found higher levels of plasma or platelet oleic acid (18:1) in subjects with ischemic heart disease (29) and in subjects who died from fatal cerebrovascular accidents and myocardial infarctions (31) . Although it is possible that these associations between monounsaturated fatty acids and coronary heart disease reflect the metabolism of dietary saturated fatty acids to monounsaturated fatty acids, none of these studies controlled for the effects of smoking or alcohol consumption.
On the basis of a report that found alcohol to be associated with higher levels of cholesterol ester palmitoleic acid and oleic acid, it was proposed that palmitoleic acid might serve as a marker of alcohol consumption (32). Cambien et al. found that smoking was associated with higher levels of cholesterol ester palmitoleic acid and oleic acid and that alcohol consumption was associated with higher levels of palmitoleic acid (25) . Leng et al. (33) also reported that smokers had higher levels of cholesterol ester oleic acid. In agreement with these studies, we found that smoking and alcohol consumption were independently associated with higher serum levels of palmitoleic acid and oleic acid.
Because studies that found monounsaturated fatty acid levels to be associated with increased risk of coronary heart disease did not control for the effects of smoking, the possibility of confounding by smoking cannot be excluded. This is relevant, because dietary monounsaturated fat intake and moderate alcohol consumption, both of which may increase blood monounsaturated fatty acid levels, may be protective against coronary heart disease (7, 34).
Polyunsaturated fatty acids
Omega-3 fatty acids. A high dietary intake of omega-3 fatty acids has been linked to lower cardiovascular disease risk in certain populations (35) . We found that smoking was associated with lower levels of phospholipid omega-3 docosahexaenoic acid (22: 6) . However, there was no association between alcohol consumption and omega-3 polyunsaturated fatty acid levels. These findings agree with those of Leng et al. (33) . Smoking is known to increase platelet aggregation (1), an effect consistent with smoking-associated differences in docosahexaenoic acid levels.
Omega-6 fatty acids. The omega-6 polyunsaturated fatty acids have not been consistently associated with coronary heart disease. Increased platelet, adipose tissue, plasma, and serum levels of linoleic acid (18:2) and increased intake of linoleic acid have been associated with a lower risk of coronary disease in some studies (22, 23, 36, 37) and a higher risk of coronary disease in others (38, 39) . None of these studies controlled for the effects of alcohol. Lower plasma and adipose tissue levels of dihomogammalinolenic acid have been reported variably to increase (23, 40) or decrease (29) coronary heart disease risk. Levels of arachidonic acid have been reported to be decreased in subjects with coronary heart disease and vascular disease (21, 23, 31, 37, (41) (42) (43) , but some of these studies did not control for the effects of smoking (21, 31, 41) .
We found that several omega-6 polyunsaturated fatty acids were associated with smoking and alcohol consumption. Smoking was associated with higher serum levels of phospholipid dihomogammalinolenic acid (20:3), a precursor of arachidonic acid and prostaglandin Ej that has been reported to reduce endothelial prostacyclin production (44, 45) . Smoking was also associated with lower serum levels of cholesterol ester and phospholipid arachidonic acid (20:4), a precursor of prostacyclin and thromboxane A 2 (44) . The association that we found between smoking and lower serum levels of arachidonic acid agrees with the findings of other studies (33, 46) . In several studies that did not control for the effects of smoking, higher levels of arachidonic acid have been found in subjects with coronary heart disease (28, 29, 47) .
Alcohol consumption was associated with lower serum levels of cholesterol ester linoleic acid (18:2). These results agree with those of other studies (24, 25, 32, 48) . Because linoleic acid inhibits platelet aggregation (44) and lowers low density lipoprotein cholesterol levels when substituted for saturated fats in the diet (49) , it may be related to decreased coronary heart disease risk. However, it has also been hypothesized that higher concentrations of linoleic acid may increase lipid peroxidation, which in turn might increase the risk of coronary heart disease (39). Alcohol consumption was also associated with higher serum levels of phospholipid adrenic acid (22:4), a metabolite of arachidonic acid. The effect of adrenic acid on coronary heart disease risk is not known.
Omega-9 fatty acids. Eicosatrienoic acid (20:3) may be associated with an increased risk of coronary heart disease (36, 41) . Unlike the omega-3 and omega-6 fatty acids, eicosatrienoic acid is a nonessential fatty acid that promotes platelet aggregation (50) . Both smoking and alcohol consumption were associated with higher levels of phospholipid eicosatrienoic acid.
Smoking, alcohol, and platelet function
We found that smoking was associated with increased levels of dihomogammalinolenic acid (20:3) and omega-9 eicosatrienoic acid (20:3) and with decreased levels of omega-3 docosahexaenoic acid (22: 6) . Each of these smoking-associated differences may increase platelet aggregation. Alcohol consumption was associated with increased levels of myristic acid (14:0), palmitic acid (16:0), and omega-9 eicosatrienoic acid (20:3) and with decreased levels of stearic acid (18:0) and linoleic acid (18:2). These alcoholassociated differences in fatty acid composition would be expected to have contradictory effects on platelet aggregation; lower levels of stearic acid should reduce platelet aggregation, whereas lower levels of linoleic acid and higher levels of myristic acid, palmitic acid, and eicosatrienoic acid should increase platelet aggregation (35, 44, 51) .
Smoking increases platelet reactivity, and alcohol consumption decreases it (1, 52) . Some of these effects may be mediated by differences in serum fatty acid composition. On the basis of our findings, this hypothesis seems more tenable for smoking than for alcohol consumption.
Limitations
Our study had a number of limitations. MRFTT enrolled middle-aged men who were at high risk for coronary heart disease; thus, caution in generalizing our results is warranted. Although we assessed the stability of the stored frozen serum specimens and found little oxidative damage, we cannot rule out the possibility that oxidative changes might have contributed to the observed differences and that an analysis of fresh serum samples would have demonstrated other associations. Our study had limited statistical power, and associations between smoking and other fatty acids might be evident in a larger study. A single 24-hour diet recall may lack the precision necessary to assess usual dietary intake accurately. Additionally, because of the large number of comparisons performed, it is possible that our findings might be the result of chance. Finally, because percentages of fatty acids were used, predicted increases in the levels of some cholesterol ester and phospholipid fatty acids would necessarily have been accompanied by corresponding decreases in the levels of other cholesterol ester and phospholipid fatty acids.
Conclusions
In previous work, using stepwise regression models that included smoking and alcohol consumption, we demonstrated that palmitic acid (16:0) is associated with an increased risk of coronary heart disease and that the omega-3 fatty acids are associated with a decreased risk of coronary heart disease and stroke (5, 6) . Our current findings, however, raise two methodological issues. First, many studies that have examined the relation of fatty acids to coronary heart disease did not adjust for the effects of smoking or alcohol consumption. Our findings-i.e., that smoking and alcohol consumption may have important effects on the fatty acid composition of serum lipoproteins-suggest that future studies of fatty acids and coronary heart disease should control for these factors. Second, a number of previous studies of the relation of smoking and alcohol consumption to serum fatty acids did not control for differences in dietary intake. Because the diets of smokers and nonsmokers and drinkers and nondrinkers differ (53) (54) (55) , detected differences in fatty acid composition in these studies may have been related to differences in dietary intake.
To our knowledge, this is one of the few studies to have comprehensively examined the relation of smoking and alcohol consumption to serum cholesterol ester and phospholipid fatty acid concentrations while adjusting for dietary fat, cholesterol, and energy intake. Because these associations were present after adjustment, our results are consistent with the hypothesis that smoking and alcohol drinking may affect the absorption, synthesis, or metabolism of fatty acids. Understanding the relation between smoking, alcohol consumption, and fatty acids is important, even for nonsmokers and nondrinkers, if cardiovascular disease risk is mediated by modifiable differences in serum fatty acid composition.
